Thiogamma I.V. Adverse Reactions

In the assessment of side effects the following frequency categories are used: Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000), Very rare (<1/10,000), Not known (cannot be estimated from the available data).
Blood and lymphatic system disorders: Very rare: Thrombopathy.
Immune system disorders: Frequency unknown: Insulin autoimmune syndrome (see Precautions).
Allergic skin reactions (urticaria, itching, eczema, skin rash), systemic allergic reactions (including anaphylactic shock).
Metabolism and nutrition disorders: Frequency unknown: As a result of the improved utilisation of glucose, blood sugar levels may fall. In such cases, hypoglycaemia-like symptoms such as dizziness, sweating, headaches and impaired vision have been observed.
Nervous system disorders: Very rare: Changes and/or disturbances to the sense of taste.
Convulsion.
Eye disorders: Very rare: Double vision.
Skin and subcutaneous tissue disorders: Very rare: Purpura.
General disorders and administration site conditions: Very rare: Infusion site reactions.
Frequency unknown: After rapid intravenous infusion, symptoms such as pressure in the head and respiratory distress may occur, although these subside spontaneously.
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.